Harvard Bioscience Profit Margin 2012-2026 | HBIO

Current and historical gross margin, operating margin and net profit margin for Harvard Bioscience (HBIO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Harvard Bioscience net profit margin as of March 31, 2026 is -65.51%.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.019B $0.087B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.722B 20.54
Kewaunee Scientific (KEQU) United States $0.100B 8.24